283 related articles for article (PubMed ID: 10535622)
1. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64.
Yu Y; Anderson LL; Li Z; Mellenberg DE; Nath R; Schell MC; Waterman FM; Wu A; Blasko JC
Med Phys; 1999 Oct; 26(10):2054-76. PubMed ID: 10535622
[TBL] [Abstract][Full Text] [Related]
2. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
3. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
4. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.
Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C
Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151
[TBL] [Abstract][Full Text] [Related]
5. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
Crook JM; Potters L; Stock RG; Zelefsky MJ
Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
[TBL] [Abstract][Full Text] [Related]
6. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
[TBL] [Abstract][Full Text] [Related]
7. AAPM Task Group 128: quality assurance tests for prostate brachytherapy ultrasound systems.
Pfeiffer D; Sutlief S; Feng W; Pierce HM; Kofler J
Med Phys; 2008 Dec; 35(12):5471-89. PubMed ID: 19175107
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry.
Su Y; Davis BJ; Furutani KM; Herman MG; Robb RA
Phys Med Biol; 2007 Jun; 52(11):3105-19. PubMed ID: 17505092
[TBL] [Abstract][Full Text] [Related]
9. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
10. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
11. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
[TBL] [Abstract][Full Text] [Related]
12. A survey of physics and dosimetry practice of permanent prostate brachytherapy in the United States.
Prete JJ; Prestidge BR; Bice WS; Friedland JL; Stock RG; Grimm PD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):1001-5. PubMed ID: 9531387
[TBL] [Abstract][Full Text] [Related]
13. Comment on "Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64" [Med. Phys. 26, 2054-2076 (1999)].
Lee PC; Moran BJ
Med Phys; 2000 Mar; 27(3):619. PubMed ID: 10757615
[No Abstract] [Full Text] [Related]
14. A simple method for dose fusion from multimodality treatment of prostate cancer: brachytherapy to external beam therapy.
Cao M; Ko SC; Slessinger ED; DesRosiers CM; Johnstone PA; Das IJ
Brachytherapy; 2011; 10(3):214-20. PubMed ID: 20843747
[TBL] [Abstract][Full Text] [Related]
15. Quality assurance/quality control issues for intraoperative planning and adaptive repeat planning of image-guided prostate implants.
Zaider M; Cohen G; Meli J; Rosenfeld AB
Int J Radiat Oncol Biol Phys; 2008; 71(1 Suppl):S152-6. PubMed ID: 18406916
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society.
Nag S; Ciezki JP; Cormack R; Doggett S; DeWyngaert K; Edmundson GK; Stock RG; Stone NN; Yu Y; Zelefsky MJ;
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1422-30. PubMed ID: 11728703
[TBL] [Abstract][Full Text] [Related]
18. Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine.
Nath R; Anderson LL; Meli JA; Olch AJ; Stitt JA; Williamson JF
Med Phys; 1997 Oct; 24(10):1557-98. PubMed ID: 9350711
[TBL] [Abstract][Full Text] [Related]
19. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
